Christopher Young: Welcome everyone and thank you for joining us. It's great to join you on my first earnings conference call as President and CEO of Vertex. Our financial results for the fourth ...

Jason Mast is a general assignment reporter at STAT focused on the science behind new medicines and the systems and people that decide whether that science ever reaches patients. You can reach Jason ...

Vertex has lost ~70% of its value despite steady growth and margin expansion, creating a compelling buy opportunity. VERX's FY26 guidance targets 10%-11% revenue growth and 23% adjusted EBITDA margin, ...

In another departure from its core focus on genetic medicines, Vertex Pharma has agreed a $4.9 billion purchase of Alpine Immune Sciences, adding a mid-stage drug candidate for kidney disease IgA ...

This article was co-authored with Emma Myer, a student at Washington and Lee University who studies Cognitive/Behavioral Science and Strategic Communication. In today’s digital age, social media has ...

M.D. Ph.D., 50 Northern Ave, Boston, Massachusetts 02210, Chief Scientific Officer, Executive Vice President, Global Research Vertex Pharmaceuticals Incorporated; Senior Lecturer on Genetics and on ...

Add Yahoo as a preferred source to see more of our stories on Google. Image Credit: Shutterstock. Greed isn’t always as obvious as someone hoarding stacks of gold like a modern-day dragon. Sometimes, ...

At each step, the programmer is able to see if, and how, a variable is affected. Trace tables are extremely useful because they enable a programmer to compare what the value of each variable should be ...